Get the Stockscreener App
0.9099
1.90%
-0.0176
After Hours:
.91
0.000100
+0.01%
Bio Path Holdings Inc stock is traded at $0.9099, with a volume of 33,061.
It is down -1.90% in the last 24 hours and down -7.78% over the past month.
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
See More
Previous Close:
$0.9275
Open:
$0.9
24h Volume:
33,061
Relative Volume:
0.10
Market Cap:
$2.32M
Revenue:
-
Net Income/Loss:
$-16.08M
P/E Ratio:
-0.4117
EPS:
-2.21
Net Cash Flow:
$-11.54M
1W Performance:
+4.59%
1M Performance:
-7.78%
6M Performance:
-77.92%
1Y Performance:
-87.70%
1-Day Range:
$0.89
$0.9299
1-Week Range:
$0.8607
$0.998
52-Week Range:
$0.8607
$21.60
Bio Path Holdings Inc Stock (BPTH) Company Profile
Name
Bio Path Holdings Inc
Sector
Industry
Phone
(832) 742-1357
Address
4710 BELLAIRE BOULEVARD, BELLAIRE, TX
Bio Path Holdings Inc Stock (BPTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-21 | Initiated | ROTH Capital | Buy |
| Nov-13-17 | Reiterated | H.C. Wainwright | Buy |
| Aug-10-16 | Reiterated | Maxim Group | Buy |
| Apr-18-16 | Initiated | Rodman & Renshaw | Buy |
| Jun-02-14 | Resumed | Maxim Group | Buy |
| May-09-14 | Initiated | Maxim Group | Buy |
View All
Bio Path Holdings Inc Stock (BPTH) Latest News
Small Interfering RNA (siRNA) Therapeutics Market Report- Expansive Coverage on the Profit Sources - openPR
Robert I. Kauffman Sells 2,481 Shares of Hagerty, Inc. (NYSE:HGTY) Stock - Defense World
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is Fred Alger Management LLC’s 9th Largest Position - Defense World
ELCO Management Co. LLC Lowers Position in Veralto Co. (NYSE:VLTO) - Defense World
Exxon Mobil Co. (NYSE:XOM) Shares Sold by Blankinship & Foster LLC - Defense World
BNY Mellon Innovators ETF (NASDAQ:BKIV) Short Interest Update - Defense World
Alpha DNA Investment Management LLC Grows Stock Position in ConocoPhillips (NYSE:COP) - Defense World
Dynamo Administracao de Recursos Ltda. Has $957,000 Stock Holdings in VTEX (NYSE:VTEX) - Defense World
Elliot Noss Sells 1,000 Shares of Tucows Inc. (NASDAQ:TCX) Stock - Defense World
Vaso Co. (OTCMKTS:VASO) Sees Significant Decrease in Short Interest - Defense World
Invesco BulletShares 2024 Corporate Bond ETF (NASDAQ:BSCO) Short Interest Update - Defense World
Innovative Food Holdings, Inc. (OTCMKTS:IVFH) Short Interest Update - Defense World
Point72 Asset Management L.P. Boosts Holdings in Planet Fitness, Inc. (NYSE:PLNT) - Defense World
1832 Asset Management L.P. Purchases 16,777 Shares of PACCAR Inc (NASDAQ:PCAR) - Defense World
Nova Vision Acquisition (NOVV) and Its Rivals Head to Head Analysis - Defense World
Valhi (NYSE:VHI) Price Target Increased to $20.00 by Analysts at Barclays - Defense World
American Tower Co. (NYSE:AMT) Shares Bought by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp - Defense World
Point72 DIFC Ltd Acquires New Stake in Carlisle Companies Incorporated (NYSE:CSL) - Defense World
Mount Yale Investment Advisors LLC Takes Position in Republic Services, Inc. (NYSE:RSG) - Defense World
Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability - Yahoo Finance
Cromwell Property Group (ASX:CMW) to Issue Interim Dividend of $0.01 - Defense World
Union Pacific (NYSE:UNP) Stock Price Down 0.6% Following Analyst Downgrade - Defense World
PATH: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Why Are Short Sellers Betting Against UiPath Inc. (PATH) Despite Its Customer-Centric Innovations? - Yahoo Finance
Healthy Upside Potential: Pathward Financial Inc (CASH) - SETE News
Gene Therapy in Oncology Market – Emerging Technologies and Growth Trends - Elektrotransports.lv
Pacer Advisors Inc. Buys New Shares in UiPath Inc. (NYSE:PATH) - Defense World
Victory Capital Management Inc. Sells 58,414 Shares of UiPath Inc. (NYSE:PATH) - Defense World
Bio-Path stock hits 52-week low at $0.89 amid sharp annual decline By Investing.com - Investing.com South Africa
Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com - Defense World
Bio-Path stock hits 52-week low at $0.89 amid sharp annual decline - Investing.com
UiPath Inc. (NYSE:PATH) Shares Acquired by Ieq Capital LLC - Defense World
1 Struggling Artificial Intelligence Stock That Wall Street Analysts Think Could Rally by More Than 40% - AOL
Bio-Path stock hits 52-week low at $0.89 amid sharp annual decline - Investing.com Australia
Bio-Path stock hits 52-week low at $0.89 amid sharp annual decline - Investing.com India
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
UiPath Inc. (NYSE:PATH) Shares Acquired by DekaBank Deutsche Girozentrale - Defense World
Ratios Uncovered: Breaking Down UiPath Inc (PATH)’s Trailing Twelve Months Metrics - The Dwinnex
It is Poised to be a Bull Market for UiPath Inc (PATH) - SETE News
UiPath Inc (PATH)’s stock price range in the last year - US Post News
Could This Be the News UiPath Shareholders Have Been Waiting For? - AOL
UiPath Inc. (NYSE:PATH) Holdings Lifted by Federated Hermes Inc. - Defense World
Bio-Path Holdings Announces Publication in Biomedicines - StockTitan
Antisense Oligonucleotide Therapeutics Market Is Expected To Observe Considerable Growth Opportunities To 2... - WhaTech
Future FinTech Group Inc. (NASDAQ:FTFT) Short Interest Update - Defense World
AddLife AB (publ) (OTCMKTS:ADDLF) Short Interest Up 12.9% in August - Defense World
Bio-Path Holdings faces Nasdaq delisting over equity issue - Investing.com
Global Antisense Oligonucleotides Market to Reach USD 5,519.6 Million by 2033, Growing at 6.6% CAGR - Market Research Blog
United States Antisense & RNAi Therapeutics Market By Application - Cineglit
Stonegate Updates Coverage on Hooker Furniture Corporation (HOFT) Q2 FY25 - Newsfile
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 24 - Clinton News Record
Bio Path Holdings Inc Stock (BPTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):